4-((2-Methyl-3-furyl)thio)-5-nonanone
Common Name: |
4-((2-Methyl-3-furyl)thio)-5-nonanone |
IUPAC Name: |
4-(2-methylfuran-3-yl)sulfanylnonan-5-one |
Molecular Formula: |
C14H22O2S |
SMILES: |
CCCCC(=O)C(CCC)SC1=C(OC=C1)C |
Inchi: |
1S/C14H22O2S/c1-4-6-8-12(15)14(7-5-2)17-13-9-10-16-11(13)3/h9-10,14H,4-8H2,1-3H3 |
Inchi Key: |
PEYZZTQOVLTVHN-UHFFFAOYSA-N |
Cas No: |
61295-50-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
254.39 |
Mass (g/mol) |
254.134 |
Molar Refractivity |
74.05 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
8 |
Rings |
1 |
TPSA |
55.51 |
Hetero Atoms |
3 |
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
5 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
102.00 to 103.00 @ 0.25 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.000213 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.64 |
LogP |
4.608 |
iLOGP |
3.35 |
XLOGP3 |
4.31 |
WLOGP |
4.61 |
MLOGP |
2.50 |
ESOL Log S |
-3.82 |
ESOL Solubility (mg/ml) |
0.038 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-5.19 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-4.91 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.79 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.136 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.923 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |